Germany Plans to Allow Homegrown and Possession of Marijuana

Regulations by 2FIRSTS.ai

Nov.28.2023

Germany Plans to Allow Homegrown and Possession of Marijuana

Germany plans to legalize the cultivation and possession of a certain quantity of marijuana for adults from April 1, 2024.

On November 27th, a legislative draft obtained by the German news agency (dpa) revealed that the German government plans to allow adults to cultivate and possess a certain quantity of marijuana starting from April 1, 2024.

Starting from July 1, 2024, it will be possible for cannabis clubs to engage in collaborative cultivation and mutual supply. Adults over the age of 18 will be permitted to possess a certain amount of cannabis, and it will also be allowed to cultivate a maximum of three cannabis plants at home.

The Social Democratic Party (SPD), the Green Party, and the health spokesperson of their parliamentary group announced in Berlin: "In the negotiations, we have agreed to shift the paradigm in drug policy concerning marijuana and recognize the social reality.

The legalization of cannabis is part of a government coalition agreement involving the three aforementioned political parties. Essentially, the plan is to remove the drug from the list of prohibited substances under the Narcotics Drugs Act.

This document still requires approval from the German parliament.

References:

[1] Alemania prevé legalizar el cultivo doméstico y la posesión de cannabis a partir del 1 de abril de 2024

Also Read:

[1] Unregulated Growth of Thailand's Recreational Cannabis Industry and Regulatory Concerns

[2] Argentina Holds 14th National Cannabis March To Protest Criminalization

[3] Colombian Justice Minister Calls for Legalization of Marijuana

#Alemania #Medical marijuana dispensary #Marijuana Vaping Products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%

Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.

Nov.18 by 2FIRSTS.ai

Mexico’s Congress Prepares Total Ban on Vapes and E-Cigarettes

Mexico’s Chamber of Deputies is preparing to vote on several major bills before the end of the legislative session, including a full ban on vapes and e-cigarettes. The proposed reform to the General Health Law would prohibit the manufacturing, sale, import, and export of these products, imposing penalties of up to eight years in prison and fines exceeding 200,000 pesos (approximately USD 11,000). L

Dec.09 by 2FIRSTS.ai

British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m

British American Tobacco’s Irish subsidiary PJ Carroll & Co Ltd reported that sales of its Velo nicotine pouches nearly quintupled in 2024 to 29 million units, driving an 11% year-on-year increase in net revenue to €33.75 million. However, amid a heavy tax burden and declining traditional cigarette volumes, the company’s pre-tax profit fell 8% to €5.69 million.

Dec.01 by 2FIRSTS.ai

UK Experts Raise Concerns Over High-Dose Nicotine Pouches Amid Rising Sales

According to The Guardian, health experts in the UK are warning about the potential health effects of high-dose nicotine pouches as their sales continue to rise. Recent studies show teenagers reporting nicotine rushes, sickness and fainting, while researchers say packaging and marketing increasingly appeal to younger age groups. Although viewed as less harmful than cigarettes, experts remain concerned about their use among non-smokers, especially adolescents.